Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland

Table 2 Factors associated with likelihood of testing

Age groups (yr)	Total number	Number monitored
12-17	17	12
< 12	13	5
Antipsychotic
Risperidone	23	13
Aripiprazole	7	4
Psychiatric diagnosis
ADHD	12	7
ASD	4	2
ADHD + ASD	6	3
ADHD + other diagnosis	6	4
ASD + other diagnosis	2	1
Average duration of antipsychotic use	Mean	SD
Group A1	15.98	1.21
Group B2	15.42	1.32
Average number of clinical reviews	Mean	SD
Group A1	3.52	0.32
Group B2	3.31	0.36

¹Group A: Group that completed physical health monitoring requirements according to National Institute for Clinical Excellence (NICE) guidelines;

²Group B: Group that did not complete physical health monitoring requirements according to NICE guidelines. ADHD: Attention deficit hyperactivity disorder; ASD: Autism spectrum disorder.